NVIDIA OpenShell 0.0.36 L7 path allowlist enforcement path traversal
| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 8.3 | $0-$5k | 0.00+ |
Summary
A vulnerability was found in NVIDIA OpenShell 0.0.36. It has been rated as very critical. This issue affects some unknown processing of the component L7 path allowlist enforcement. Performing a manipulation results in path traversal. This vulnerability was named CVE-2026-100971. The attack needs to be approached locally. There is no available exploit.
Details
A vulnerability, which was classified as very critical, was found in NVIDIA OpenShell 0.0.36. This affects an unknown function of the component L7 path allowlist enforcement. The manipulation with an unknown input leads to a path traversal vulnerability. CWE is classifying the issue as CWE-22. The product uses external input to construct a pathname that is intended to identify a file or directory that is located underneath a restricted parent directory, but the product does not properly neutralize special elements within the pathname that can cause the pathname to resolve to a location that is outside of the restricted directory. This is going to have an impact on confidentiality, integrity, and availability. The summary by CVE is:
NVIDIA OpenShell for Linux contains a vulnerability in the L7 path allowlist enforcement component where a local attacker with low privileges could cause path traversal by using semicolon-dot path sequences to bypass allowlist restrictions. A successful exploit of this vulnerability might lead to information disclosure, data tampering, and denial of service.
This vulnerability is uniquely identified as CVE-2026-100971 since 09/27/2026. The exploitability is told to be easy. Attacking locally is a requirement. It demands that the victim is doing some kind of user interaction. The technical details are unknown and an exploit is not publicly available. The pricing for an exploit might be around USD $0-$5k at the moment (estimation calculated on 11/17/2026). The attack technique deployed by this issue is T1006 according to MITRE ATT&CK.
There is no information about possible countermeasures known. It may be suggested to replace the affected object with an alternative product.
Statistical analysis made it clear that VulDB provides the best quality for vulnerability data.
Product
Vendor
Name
Version
License
Website
- Vendor: https://www.nvidia.com/
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔒VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 8.3VulDB Meta Temp Score: 8.3
VulDB Base Score: 8.2
VulDB Temp Score: 8.2
VulDB Vector: 🔒
VulDB Reliability: 🔍
CNA Base Score: 8.4
CNA Vector (nvidia): 🔒
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔒
VulDB Temp Score: 🔒
VulDB Reliability: 🔍
Exploiting
Class: Path traversalCWE: CWE-22
CAPEC: 🔒
ATT&CK: 🔒
Physical: Partially
Local: Yes
Remote: Partially
Availability: 🔒
Status: Not defined
Price Prediction: 🔍
Current Price Estimation: 🔒
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: no mitigation knownStatus: 🔍
0-Day Time: 🔒
Timeline
09/27/2026 CVE reserved11/17/2026 Advisory disclosed
11/17/2026 VulDB entry created
11/17/2026 VulDB entry last update
Sources
Vendor: nvidia.comStatus: Confirmed
CNA: nvidia
CVE: CVE-2026-100971 (🔒)
GCVE (CVE): GCVE-0-2026-100971
GCVE (VulDB): GCVE-100-438123
Entry
Created: 11/17/2026 17:27Changes: 11/17/2026 17:27 (60)
Complete: 🔍
Cache ID: 216::103
Statistical analysis made it clear that VulDB provides the best quality for vulnerability data.
No comments yet. Languages: en.
Please log in to comment.